Cargando…
Phosphorylation Modifications Regulating Cardiac Protein Quality Control Mechanisms
Many forms of cardiac disease, including heart failure, present with inadequate protein quality control (PQC). Pathological conditions often involve impaired removal of terminally misfolded proteins. This results in the formation of large protein aggregates, which further reduce cellular viability a...
Autores principales: | Mishra, Sumita, Dunkerly-Eyring, Brittany L., Keceli, Gizem, Ranek, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689282/ https://www.ncbi.nlm.nih.gov/pubmed/33281625 http://dx.doi.org/10.3389/fphys.2020.593585 |
Ejemplares similares
-
Targeting Protein Kinase G to Treat Cardiac Proteotoxicity
por: Oeing, Christian U., et al.
Publicado: (2020) -
Editorial: Post-translational Modifications and Compartmentalized Protein Quality Control in Cardiac Muscle and Disease
por: Ranek, Mark J., et al.
Publicado: (2021) -
CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
por: Ranek, Mark J., et al.
Publicado: (2020) -
Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt
por: Dunkerly-Eyring, Brittany L, et al.
Publicado: (2022) -
Editorial: Targeting Cardiac Proteotoxicity
por: Ranek, Mark J., et al.
Publicado: (2021)